Viewing Study NCT02556203


Ignite Creation Date: 2025-12-24 @ 7:14 PM
Ignite Modification Date: 2025-12-29 @ 3:05 PM
Study NCT ID: NCT02556203
Status: TERMINATED
Last Update Posted: 2020-01-13
First Post: 2015-09-05
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Global Study Comparing a rivAroxaban-based Antithrombotic Strategy to an antipLatelet-based Strategy After Transcatheter aortIc vaLve rEplacement to Optimize Clinical Outcomes
Sponsor: Bayer
Organization: